Key Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Key Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.55K	Buy	131 +121	+1,210%	+$6.95K	﹤0.01%	370
2026 Q1	$607	Buy	10 +2	+25%	+$117	﹤0.01%	640
2025 Q4	$432	Buy	+8	New	+$385	﹤0.01%	487

Other funds holding BMY

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Key Capital Management's BMY Position: Q2 2026 in Review

Key Capital Management increased its Bristol-Myers Squibb (BMY) stake by 1,210% in Q2 2026, buying an estimated $6.95K and bringing the position to 131 shares worth $7.55K. The position accounts for ﹤0.01% of the portfolio, ranked #370.

Key Capital Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 1,487 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Key Capital Management held 131 shares of Bristol-Myers Squibb worth $7.55K as of Q2 2026.
Key Capital Management bought 121 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.95K.
Bristol-Myers Squibb made up ﹤0.01% of Key Capital Management's portfolio in Q2 2026, its #370 holding.
Key Capital Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
1,487 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Key Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.